Section Arrow
Quote
KMDA.NASDAQ
- Kamada Ltd
Quotes are at least 15-min delayed:2025/02/23 10:36 EST
Last
 7.46
-0.17 (-2.23%)
Day High 
7.79 
Prev. Close
7.63 
1-M High
9.155 
Volume 
223.18K 
Bid
7.35
Ask
7.5
Day Low
7.33 
Open
7.67 
1-M Low
6.6201 
Market Cap 
438.67M 
Currency USD 
P/E 28.26 
%Yield -- 
10-SMA 7.8 
20-SMA 7.35 
50-SMA 6.79 
52-W High 9.155 
52-W Low 4.74 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.27/1.21
Enterprise Value
446.10M
Balance Sheet
Book Value Per Share
4.44
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
142.52M
Operating Revenue Per Share
2.54
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed：2025/02/23 10:36 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.